Evidence map›Paper›PMID 39422065›Full record

ArticleSmall (Weinheim an der Bergstrasse, Germany)2024

Reduced Non-Specific Binding of Super-Resolution DNA-PAINT Markers by Shielded DNA-PAINT Labeling Protocols.

Evelina Lučinskaitė, Alexandre F E Bokhobza, Andrew Stannard, Anna Meletiou, Chris Estell, Steven West, Lorenzo Di Michele, Christian Soeller, Alexander H Clowsley

Abstract read
In one paragraph

Article in Small (Weinheim an der Bergstrasse, Germany), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Evelina LučinskaitėDepartment of Physiology, University of Bern, Bern, 3012, Switzerland.
Alexandre F E BokhobzaDepartment of Physiology, University of Bern, Bern, 3012, Switzerland.ORCID 0000-0001-7953-4328
Andrew StannardDepartment of Chemistry, Imperial College London, London, W12 OBZ, UK.ORCID 0000-0001-6283-667X
Anna MeletiouDepartment of Physiology, University of Bern, Bern, 3012, Switzerland.
Chris EstellLiving Systems Institute, University of Exeter, Stocker Road, Exeter, EX4 4QD, UK.
Steven WestLiving Systems Institute, University of Exeter, Stocker Road, Exeter, EX4 4QD, UK.ORCID 0000-0002-7622-9050
Lorenzo Di MicheleDepartment of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge, CB3 0AS, UK.ORCID 0000-0002-1458-9747
Christian SoellerDepartment of Physiology, University of Bern, Bern, 3012, Switzerland.ORCID 0000-0002-9302-2203
Alexander H ClowsleyDepartment of Physiology, University of Bern, Bern, 3012, Switzerland.ORCID 0000-0001-9318-1557

Funding

Bio-Techne and the University of ExeterBiotechnology and Biological Sciences Research Council BB/T007176/1
6 · The paper itself

Abstract

The DNA-based single molecule super-resolution imaging approach, DNA-PAINT, can achieve nanometer resolution of single targets. However, the approach can suffer from significant non-specific background signals originating from non-specifically bound DNA-conjugated DNA-PAINT secondary antibodies as shown here. Using dye-modified oligonucleotides the location of DNA-PAINT secondary antibody probes can easily be observed with widefield imaging prior to beginning a super-resolution measurement. This reveals that a substantial proportion of DNA probes can accumulate, non-specifically, within the nucleus, as well as across the cytoplasm, of cells. Here, Shielded DNA-PAINT labeling is introduced, a method using partially or fully double-stranded docking strand sequences, prior to labeling, in buffers with increased ionic strength to greatly reduce non-specific interactions in the nucleus as well as the cytoplasm. This new labeling approach is evaluated against various conditions and it is shown that applying Shielded DNA-PAINT can reduce non-specific events approximately five-fold within the nucleus. This marked reduction in non-specific binding of probes during the labeling procedure is comparable to results obtained with unnatural left-handed DNA albeit at a fraction of the cost. Shielded DNA-PAINT is a straightforward adaption of current DNA-PAINT protocols and enables nanometer precision imaging of nuclear targets with low non-specific backgrounds.

Indexed as

DNADNA ProbesHumansStaining and LabelingDNADNA ProbesDNA‐PAINTimmunostainingsingle moleculesuper‐resolution

Identifiers

PMID39422065
PMCPMC11657032

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.